About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, September 3rd, 2013

The QualityStocks
Daily Stock List


Petro River Oil Corp. (PTRC)

PennyStocks24 reported recently on Petro River Oil Corp. (PTRC), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Founded in 2011, Petro River Oil Corp. is an independent exploration and production company. The Company focuses on their oil properties in the Mississippi Lime play in eastern Kansas. Petro River Oil has accumulated nearly 100,000 acres with a broad inventory of low cost, high return development drilling opportunities.

The Mississippi Lime play covers approximately 17 million acres in Oklahoma and Kansas, in comparison to 10- to 15 million acres in the Bakken and 6 million in the Eagle Ford. In addition, Petro River Oil has considerable acreage and oil reserves in the State of Missouri. TheircurrentOil and Gas portfolio consists of 60,105 gross/40,591 net acres in Missouri, Kentucky, and Montana.

Petro River Oil Corp.completedseveral related transactions through which the Company acquired control of Petro River Oil, LLC (Petro LLC) and Petro’s wholly-owned subsidiary Petro River Operating, LLC. Petro River Oil Corp. is based in Houston, Texas. The Company’s shares trade on the OTC Bulletin Board.

Petro LLC is an emerging oil and gas producer that controls a substantial acreage position in the Southeast Kansas region of the Mississippi Lime formation. Because of the acquisition of Petro River Oil, the Company has added 115,000 gross/85,000 net acres to their Oil and Gas portfolio. This includes five producing oil and gas wells in which Petro owns a 50 percent Working Interest (WI)and a 40 percent Net Revenue Interest (NRI).

This has established a majorpresence in the Mississippi Lime play. This acreage is in addition to the Company's present Oil and Gas portfolio. Petro River Oil has also acquired more than 60 square miles of proprietary 3D seismic data over prospective Mississippi Lime acreage in the sameregion. As part of this acquisition, WI’s in leases in which Petro River Oil already has a stake were acquired from Mega Partners I for approximately 15.5mm shares.

Petro River Oil Corp. (PTRC), closed Tuesday’s trading session at $0.21, even for the day, on 802,061 volume with 83 trades. The average volume for the last 60 days is 270,188 and the stock's 52-week low/high is $0.0052/$0.56.

Excel Corp. (EXCC)

Today we are reporting on Excel Corp. (EXCC), here at the QualityStocks Daily Newsletter.

Incorporated in 2012,Excel Corp.has been in a developmental phase since establishment and presently has two lines of business operations. These are licensing and providing credit and debit card processing services.During the second quarter of 2013, the Company started servicing a limited amount of merchants. Excel lists on the OTC Markets’ OTCQB. The Company has their corporate headquarters in New York, New York.

On January 14, 2013, Excel entered into an Agreement of Merger and Plan of Reorganization with Excel Business Solutions, Inc., a Delaware corporation (EBSI), and ECB Acquisition Corp., Excel’s newly formed, wholly-owned Delaware subsidiary. Upon closing of the transaction contemplated under the Merger Agreement, the ECB Acquisition subsidiary merged with and into EBSI. EBSI, as the surviving corporation, became a wholly-owned subsidiary of EXCEL.

With the terms and conditions of the Merger Agreement, at the closing of the Merger, each share of EBSI's common stock issued and outstanding immediately prior to the closing of the Merger underwent conversion into the right to receive an aggregate of 33,532.446 shares of common stock, par value $0.0001 per share, of Excel, with fractional shares of the Company's common stock rounded up or down to the nearest whole share.

Pertaining to Excel’s licensing business, the Company is concentrating on bringing national and global brands to the retail marketplace. Excel acts as an agent for licensing brands of corporations, people, government agencies, and more. The Company’s intention is to obtain agent rights to license select brands where the brand name can be leveraged into new categories.

Excel’s goal is to develop avaried portfolio of iconic consumer brands through creating and facilitating relationships between Licensors and retail businesses, wholesale businesses, manufacturers, and more. The Company expects to organically grow the existing portfolio and enter into Joint Ventures (JVs) or other partnerships with the aim of taking advantage of the experience of agent management and that of their licensees to enablesales of branded products.

Excel’s intention is to seek the rights to license brands and enter into license relationships with domestic and/or globalpartners that have demonstrated thecapabilityto produce quality products that have been successfully marketed and sold domestically and/or worldwide in a wide spectrum of products categories.

Excel Corp. (EXCC), closed Tuesday’s trading session at $0.0341, down 33.14%, on 75,000 volume with 7 trades. The average volume for the last 60 days is 64,717 and the stock's 52-week low/high is $0.015/$0.169.

OncoSec Medical, Inc. (ONCS)

PennyStocks24 and Stock Analyzer reported earlier on OncoSec Medical, Inc. (ONCS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OncoSec Medical, Inc.is a biopharmaceutical companydeveloping their advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors.The Company’smission is to pioneer and refine new electroporation technologies that strive to benefit patients and improvethe quality of life for those whose skin cancers cannot be treated effectively with conventional treatment approaches.OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. OncoSec Medical has their corporate headquarters in San Diego, California. The Company’s shares trade on the OTCQB.

OncoSec’s ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution for less invasive and less expensive therapies that canlessendetrimental effects resulting from presentlyavailable cancer treatments. These currently available treatmentsinclude surgery, systemic chemotherapy, or immunotherapy and other treatment alternatives.

The foundation of the Company’s core technology is upon their proprietary use of an electroporation platform to enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of assorted solid cancers using these targeted anti-cancer agents has demonstrated selective destruction of cancerous cells; this is while potentially sparing healthy normal tissues during early and late stage clinical trials.

In July,OncoSec Medical announced interim immune response data from their Phase II study of ImmunoPulse in patients with metastatic melanoma. Findings showed that the Company’s ImmunoPulse demonstrated a considerablechange in tumor immunity following treatment with DNA IL-12 and electroporation. Dr. Adil Daud presented the data at the 8th World Congress of Melanoma in Hamburg, Germany. Dr. Daud is principal investigator at the University of California San Francisco.

Twenty-five patients with stage III or IV cutaneous and in-transit metastatic melanoma were enrolled in the Phase II, single-arm, open-label and multi-center study. The design of the trial is to measure local and distant objective response following treatment of cutaneous melanoma lesions with DNA IL-12 and electroporation with a primary endpoint of 24 weeks.

OncoSec Medical, Inc. (ONCS), closed Tuesday’s session at $0.29, down 1.69%, on 894,599 volume with 117 trades. The average volume for the last 60 days is 1,191,302 and the stock's 52-week low/high is $0.182/$0.485.

U.S. Precious Metals, Inc. (USPR)

FN Media, Investor Ideas, PennyStocks24, RockingPennyStocks, Pennystocktweeters.com,PennyStock Tweets, fusionspicks, Stocks That Move, MarkeyWireStocks, Financial News Media, and Pennybuster reported earlier on U.S. Precious Metals, Inc. (USPR), and we highlight the Company, here at the QualityStocks Daily Newsletter.

U.S. Precious Metals, Inc.,headquartered in Marlboro, New Jersey, involves in the acquisition, exploration, as well as development of mineral properties. Trading on the OTCQB, the Company’s mission is to discover, acquire, define, and develop gold deposits and other valuable metals. Their development projects are chiefly in Mexico, but additionally throughout the Americas.

An exploration stage company, U.S. Precious Metals is focusing on gold and base minerals primarily located in the State of Michoacán, Mexico. The Companyowns exclusive exploration and exploitation rights to approximately 37,000 acres of land in Michoacán. The 17,000-hectare Solidaridad mining leases are held by U.S. Precious Metals of Mexico, a wholly owned subsidiary of U.S. Precious Metals.

The Solidaridad properties consist of eight concessions granted by the Mexican government for a 50-year period. All information available to the Company has been attained from boreholes drilled by them and by the previous two companies that explored the property and analyzed under chain of custody by an independent laboratory. 

In May of this year,U.S. Precious Metals announced that on May 22, 2013, the Company entered into an agreement with Mesa Acquisitions Group, LLC, in association with Alba Petroleos, to further explore and develop U.S. Precious Metals’ Mexican concessions. Mesa Acquisitions/Alba Petroleos has committed to spend up to approximately $50 million to explore and develop pre-determined portions of two of U.S. Precious Metals’ Mexican concessions known as Solidaridad 1 & Solidaridad 2.

Moreover, they will build the necessary plant and/or bring in the needed equipment to process the head ore. In return, they will receive 10 million shares of U.S. Precious Metals common stock and receive a 30 percent interest of the project. U.S. Precious Metals will retain 70 percent of the project.

U.S. Precious Metals hasacquired Resource Technology Corp. Therefore, the Company has incorporated the newest technological advancements in ore refining by embracing Thermal processing, which is set to transform the way ore undergoes processing in the future. In addition, U.S. Precious Metalshas commenced extensive work by way of Satellite Imaging on their Mexican concessions. This will supplement the existing, more traditional data that has been accumulated over the years.

U.S. Precious Metals, Inc. (USPR), closed at $0.18, down 1.04%, on 56,870 volume with 12 trades. The average volume for the last 60 days is 170,059 and the stock's 52-week low/high is $0.09/$0.2899.

TapImmune, Inc. (TPIV)

Ceocast News reported earlier on TapImmune, Inc. (TPIV) and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.

TapImmune, Inc. is a vaccine technologies company that specializes in the development of innovative gene based immunotherapeutics and vaccines in the areas of oncology and infectious disease. The Company's lead product candidates include peptide and nucleic acid-based vaccine technologies designed to restore and/or augment antigen presentation and subsequent recognition and killing of cancer cells by the immune system.

TapImmune’s shares trade on the OTC Bulletin Board. Founded in 1999, the Company has their headquarters in Seattle, Washington.TapImmune is developing cancer vaccines that combine the use of novel antigens together with their TAP expression technology.TapImmune’stechnology has wide-ranging applications in developing therapeutic and preventative vaccines.

TapImmune is developing TAP-based prophylactic vaccines commercially suitable for the prevention of infectious diseases and as Biodefense agents. As a vaccine component, the gene based TAP technology has the potential to improve the efficacy of prophylactic and immunotherapeutic vaccines significantly, as it addresses a fundamental mechanism for T cell recognition and response. TAP expression also has the unique ability to enhance the effector function of mature killer T cells. This enhancement of effector function is potentially complementary to any/all vaccine approaches that are designed to enhance cellular responses.

TapImmune has started treating patients in their first Phase 1 immunotherapy clinical trial targeting HER2/neu in breast cancer at the Mayo clinic. This trial uses patented antigen technologies developed at the Mayo clinic and will follow patients for safety and immune responses as the primary endpoints. TapImmune has the exclusive Option to license this technology.

This past June, TapImmuneprovided a corporate update on development programs and collaborations. Highlights for the Company include positive progress at the MAYO clinic on the phase 1 HER2/neu clinical trial. TapImmune expects interim results in the near term.

Highlights also include a new antigen acquisition and IND filing update. This makes what the Company believes will be the most completeHER2/neu product on the market with wider application in other cancers. Furthermore, highlights include considerable development of new IP. This includes a novel expression system, which has already proven to be a very valuable component of the Company’s own platforms or as a new stand-alone therapy.

Moreover, highlights also include successful advancement of the infectious disease (Smallpox) program at the Mayo Clinic and anexpansionof the scope to include emerging pathogens posing worldwidethreats.

TapImmune, Inc. (TPIV), closed Tuesday’strading at $0.012, even for the day, on 477,257 volume with 12 trades. The average volume for the last 60 days is 1,077,751 and the stock's 52-week low/high is $0.0075/$0.16.

Global Earth Energy, Inc. (GLER)

StocksGoneWild reported last week on Global Earth Energy, Inc. (GLER), PennyStocks24, Stock Analyzer, MarketWireStocks, InsideBulls, Penny Trackers, and Center Stage Stocks did earlier, and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Global Earth Energy, Inc. is an oil and gas explorationenterprise. Theyconcentrate on developing prime prospects in the United States. The Company works with some of the foremostindependent oil and gas drillers and operators in the industry.Thus, they reduce the risks normallyassociated with the drilling of wells. Global Earth Energy announced in 2013 a new wide-ranging growth strategy focused on the acquisition of overriding royalty interests in oil and gas leases in the U.S. The Company will acquire leases from landowners with the objective of rolling up a multitude of leases covering several thousand acres.

Founded in 2004, Global Earth Energy has their corporate headquarters in Wilmington, North Carolina. The Company’s shares trade on the OTC Markets’ OTCQB.The Company previously went by the name Global Wataire Inc. They changed their name to Global Earth Energy, Inc. in February of 2008.Through accruing a large land package, Global Earth Energy believes they will be preparedas an attractive takeover target for larger oil and gascorporations. 

Global Earth Energy is alsoworking to widen their corporate strategic direction.Earlier this year, their President, Mr. Sydney A. Harland, announced that the Company would acquire an income-producing asset. This is the Naylor Apartment Complex, located at 2585 Naylor Road SE, Washington, DC 20020. This is a multi-unit (15) complex. Gross Revenues are $231,135.00.

Furthermore, in May 2013, they announced that they would acquire a second income-producing asset, the Honeywell Apartment Complex, located at 2103-15 & 2115-17 Honeywell Avenue, Bronx, New York 10460. It is Multi-Unit-198. The acquisition price was $26,000,000.00. Gross Revenue is $3,200,000.00. In addition, in May, Global Earth Energy announced that the Company, through a Letter of Intent (LOI), intends to acquire a third income-producing asset, the Sunrise Highway Office Building, located at 381 Sunrise Highway, Lynbrook, New York 11563. This acquisition will only occur if Global Earth Energy and the seller of the property can execute a binding agreement of sale and purchase.

Likewise, in May, the Company announced that they, through an LOI, intend to acquire an additional asset; Country Road Office Building, situated at 1670 Old Country Road, Plainview, New York 11803. Likewise, the acquisition will only occur if the Company and the seller of the property can execute a binding agreement of sale and purchase.

Last week,Global Earth Energyannounced a partnership with Hawk Manufacturing, Inc. Each company will take a respective 20 percent stake in the other. The value of the transaction is almost $5,000,000.00 between the two firms. Global Earth Energy is receiving $4,300,000.00 worth of stock from Hawk Manufacturing.Hawk is acquiring companies that manufacture complementary products. When combined, these acquisitions would enable the sharing of resources and provide customer diversification opportunities.

Global Earth Energy, Inc. (GLER), closed Tuesday at $0.0002, even for the day, on 36,276,333 volume with 35 trades. The average volume for the last 60 days is 16,409,272 and the stock's 52-week low/high is $0.0001/$0.04.

Probe Manufacturing, Inc. (PMFI)

OTCPicks reported previously on Probe Manufacturing, Inc. (PMFI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Probe Manufacturing, Inc. isan international electronics design & manufacturing services enterprise. The Companyprovides innovators with business services by way of their factory in California and factories around the world.Probe generates their revenue from sales of their services mainly to medical device, aerospace/military, telecommunication, alternative fuel, industrial and instrumentation product manufacturers’ customers. The majority of the Company’s revenue is from manufacturing a mix of complex printed circuit board assemblies (PCB), and box build assemblies. Headquartered in Irvine, California, Probe has been serving the aforementioned industries since 1994.

Probe Manufacturing Industries, Inc. incorporated on July 7, 1995. On April 21, 2005, the Company was re-domiciled from California to Nevada; they changed their corporate name to Probe Manufacturing, Inc. The Company’sstrategy is to build and pursue international opportunities leveraging core competencies and to increase their manufacturing foundry platform for innovative start-ups and technology companies in return for manufacturing rights and equity.

Probe providestheir worldwide design and manufacturing services to original electronic equipment manufacturers (OEMs) from their 23,000 sq. ft. facility in Irvine, California, as well as Trident Manufacturing's 16,000 sq. ft. facility in Salt Lake City, Utah, which Probe acquired in the first quarter of 2013.

Probe Manufacturing provides Electronics Manufacturing Services (EMS). The Company’s EMS offerings include new product introduction, collaborative design, procurement and materials management, product manufacturing, product warranty repair, and end-of-life support. Probe offers their customers all-inclusiveand integrated design and manufacturing services, from initial product design to production and direct order fulfillment.

The Company’s engineering services include product design, printed circuit board layout, prototyping, and test development. Probe’s supply chain management solutions include purchasing, management of materials, and order fulfillment. Their manufacturing services include printed circuit board assembly, cable assembly, mechanical assembly, and fully integrated box build systems for high complexity electronics.

This past June,Probe Manufacturing reported sales of approximately $713,000 for the three months ended March 31, 2013. First Quarter 2013 highlights includenew customer orders of approximately $1,000,000; completion of the acquisition of Trident Manufacturing, Inc., anElectronics Manufacturing Services (EMS) in Salt Lake City, Utah, andinvestment in new manufacturing equipment, infrastructure and personnel, including the addition of a new director of engineering.

First Quarter highlights additionally include thelaunch of manufacturing certification of AS9100 in the defense and ISO13485 in the medical industries;recapitalization of the Company’s capital structure, and retention of Probe’s customer base.

Probe Manufacturing, Inc. (PMFI), closed at $0.12, up 4.35%, on 30,000 volume with 1 trade. The average volume for the last 60 days is 23,159 and the stock's 52-week low/high is $0.05/$0.18.

Flux Power Holdings, Inc. (FLUX)

PennyStocks24, StockMister, Penny Stock Pick Alert, Winning Penny Stock Picks, WePickPennyStocks, Super Hot Penny Stocks, RisingPennyStocks, Super Nova Stock Picks, PennyStockMoneyTrain, Penny Stock Pick Report, Liquid Tycoon, PennyPickAlerts, and Joe Penny Stocks reported earlier on Flux Power Holdings, Inc. (FLUX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Based inEscondido,California, Flux Power Holdings, Inc. designs, develops, and sells cost efficient advanced energy storage systems.The Company sells modular advanced energy storage products via distributors and directly to original equipment manufacturers (OEMs).Flux Power's advanced systems technologies significantlyextend cycle life and improve system performance.Incorporated in October of 2009, Flux Power Holdings lists on the OTC Markets’ OTCQB.

Flux Power provides lithium energy storage solutions to a number of markets. These include wind, solar, and backup power. The Company’s product offerings presently include batteries in differentsizes and forms, packaged modules, fully advanced energy storage systems, as well as various system accessories. These accessories include stand-alone battery management, stackable chargers, programming software, and display systems.

The Company creates intelligent Battery Management System Modules (BMSM), Battery Control Modules (BCM), and smart chargers, with included energy monitoring/display solutions (EMS).Flux Power’sBMSM systems enable up to five times the cycle life; this equates to thousands of charge/discharge cycles or years of use.

The Company’s usual markets are the material handling equipment industry; hybrid and electric vehicles (EV, HEV, and PHEV), OEM and private brand; utility grid storage systems used in peak-shaving; off-grid photo-voltaic installations, both large and small, and energy back-up systems implementing Uninterruptible Power Supplies (UPS).

In late June 2013,Flux Power Holdings announced that they entered into a non-binding Letter Of Intent (LOI) to acquire KleenSpeed Technologies. KleenSpeed develops technology for distributed energy markets, including grid storage. 

The LOI propositionsthat upon the successful closing of the acquisition, KleenSpeed Technologies will become a wholly-owned subsidiary of Flux Power Holdings and Flux Power's Board of Directors will be increasedfrom three members to five members with KleenSpeed's current Chief Executive Officer, Mr. Timothy Collins, joining the Board of Flux Power Holdings and assuming the role of Executive Chairman of Flux Power.The expectation is that the acquisition will be completed within the next 12 months (from the end of June 2013). 

Flux Power Holdings, Inc. (FLUX), closed Tuesday at $0.059, up 37.21%, on 5,000 volume with 1 trade. The average volume for the last 60 days is 62,386 and the stock's 52-week low/high is $0.028/$2.25.


The QualityStocks
Company Corner


On the Move Systems, Inc. (OMVS)

The QualityStocks Daily Newsletter would like to spotlight On the Move Systems, Inc. (OMVS). Today, On the Move Systems, Inc. closed trading at $0.32, up 10.34%, on 85,457 volume with 37 trades. The stock’s average daily volume over the past 60 days is 69,000, and its 52-week low/high is $0.0027/$0.403.

On The Move Systems Corp. announced today that they are seeking out intermodal transport companies to offer the first services made available via their online transportation and freight portal which is set to revolutionize the way cargo transport services are bought and sold. A new online platform that applies the same business model used by companies such as Expedia, Travelocity and more to travel and transportation options not offered by its larger competitors is just the start and now, OMVS stands ready to ink its first partnering agreement with a freight carrier, even as more private charter and freight companies continue responding in droves.

On the Move Systems, Inc. (OMVS) has established a scalable business model for leveraging the available routes and “legs” of private aviation to book private air charter, freight, and animal/exotic transport services. Their unique ISTx software is designed for managing and supporting services and routes across multiple private/commercial carriers through this single platform.

Management places strong emphasis on customer satisfaction and approaches this viewpoint by creating a unique flight or service profile for each client. The company has developed a business model offering this profile access through various proprietary and membership models. Additionally, its business strategy incorporates acquiring or joining with smaller charter plane owners. The company has further established various divisions which address particular client needs and routes. Leveraging its unique business model with a host of innovative solutions for expanding markets, OMVS is well positioned for rapid growth.

Current divisions of OMVS include Charter Services, Inter-Modal Freight, and Animal/Exotic Transport. The Charter Services Division offers private charter airplane owners the opportunity to enter a network where available planes will be "on-call" to deliver private air charter service on demand. The Inter-Modal Freight Division provides charter and freight shipping services to clients who need to expedite shipment of cargo and freight globally – including medical transport for tissue and isotopes. The company's Animal/Exotic Transport Division affords clients the security of transporting pets and animals without the accompaniment of the owner.

OMVS continues to develop technology and applications that connect all business touch points - passengers, assets, and routes. The company intends to monitor daily operations through a single platform providing ultimate support for all business activities. OMVS is in the final stages of development with the ISTx platform and plans to implement system wide in the next two fiscal quarters. Disclaimer

On the Move Systems, Inc. Company Blog

On the Move Systems, Inc. News:

OMVS Begins Portal Build-Out

OMVS Appoints New CEO to Implement Transportation Business Model

OMVS Scouts Intermodal Freight Targets

DoMark Internatioxnal, Inc. (DOMK)

The QualityStocks Daily Newsletter would like to spotlight DoMark International, Inc. (DOMK). Today, DoMark International, Inc. closed trading at $0.0739, up 9.81%, on 389,964 volume with 43 trades. The stock’s average daily volume over the past 60 days is 404,901, and its 52-week low/high is $0.0322/$0.695.

DoMark International, Inc. was pleased to announce today that they have increased their holding in Imagic Ltd. to 31% for cash, in a transaction whereby Imagic has acquired all of the IP and rights to the Wireless Cartridge Printer, adding to an already strong patent-pending lineup that includes the SmartLink device and handheld Smartlink games controller unit. SmartLink connects smartphones and tablets of any make wirelessly to the television set with 100% digital reproduction of movies/games and this move, ahead of the global SmartLink launch, adds some nice weight to the product mix with the portable/wireless Imagic Cartridge Printer.

DoMark International, Inc. (DOMK) is focused on researching, evaluating, and acquiring profitable private firms in the business segments of sports, technology, medical, energy, and business services. By providing the financial and human capital necessary to deal with overwhelming administrative, planning, governance, compliance, and regulatory challenges, its newly acquired partners can focus their energy and flourish.

Through its wholly owned subsidiary, SolaWerks, Inc., DoMark is committed to revolutionizing the efficiency and capabilities of a new generation of mobile devices. The subsidiary's current focus is on developing and distributing the SolaPad, a combined cover and charging system for Apple's iPad, and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone.

Musclefoot, Inc., another wholly owned subsidiary of DoMark, is engaged in the distribution, marketing, and sale of Barefoot Science, the revolutionary patented foot care system designed to relieve foot and back pain as well as improve athletic performance. With a strong commitment to customer service and security, DoMark plans to expand its marketing relationships across a far broader product set.

The management team has positioned the company to capitalize on emerging opportunities by working with the world's most forward-thinking companies to develop and market game-changing products with the promise of long-term financial growth. Leveraging the expertise of its team, the company continues to evaluate acquisition candidates and products targeting underserved markets to increase its growth potential. Disclaimer

DoMark International, Inc. Blog

DoMark International, Inc. News:

DoMark Increases Holding in Imagic Ltd. Ahead of SmartLink Global Launch

DoMark Acquires Unique Wireless Portable Plug and Print Patent Pending Printer for Smartphone/Digital Cameras

DoMark International Inc. Purchases 20% of Zaktek Ltd.

Advaxis, Inc. (ADXS)

The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $3.21, even with yesterday's close, on 53,546 volume with 117 trades. The stock’s average daily volume over the past 60 days is 4,483, and its 52-week low/high is $2.60/$19.375.

Advaxis Inc. announced today that three abstracts describing research with the company's Lm-LLO immunotherapies have been selected for poster presentation at the Society for Immunotherapy of Cancer 28th Annual Meeting, November 8-10, at the Gaylord National Hotel & Convention Center in National Harbor, MD. Together, the data in these abstracts paints a picture of an immunotherapy solution set which has a strong positive impact on the immune system while at the same time counteracts immune suppression in the tumor microenvironment which can lead to apparent prolonged survival and objective tumor responses from a single immunotherapeutic agent.

Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.

The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.

Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.

The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer

Advaxis, Inc. Company Blog

Advaxis, Inc. News:

Advaxis Announces Three Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer Annual Meeting

Advaxis Appoints Daniel J. O’Connor President and CEO and Elects Dr. James Patton Non-Executive Chairman of the Board

Advaxis’ ADXS-HPV Granted Orphan Drug Designation for Treatment of HPV-Associated Anal Cancer

Raptor Resources Holdings Inc. (RRHI)

The QualityStocks Daily Newsletter would like to spotlight Raptor Resources Holdings Inc. (RRHI). Today, Raptor Resources Holdings Inc. closed trading at $0.023, up 27.78%, on 10,000 volume with 1 trades. The stock’s average daily volume over the past 60 days is 156,732, and its 52-week low/high is $0.0002/$0.0395.

Raptor Resources Holdings Inc. (RRHI) is a publicly traded holdings company focused on mineral resource acquisition, exploration, and development. The company currently has two subsidiaries: Mabwe Minerals Inc. (MBMI), a natural resources and hard asset company engaged in the mining and commercial sales of industrial minerals & metals with first focus on barite; and TAG Minerals Inc., a mineral & metal resource acquisition, exploration, and development company with first focus on alluvial surface gold.

Mabwe Minerals has been the focus of the parent company’s efforts the last two years to move into commercial barite production. RRHI shareholders share a common interest with MBMI shareholders in the success of Dodge Mine as the parent company owns 90M shares of MBMI. The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc.

TAG Minerals, along with its indigenous affiliate, TAG Minerals Zimbabwe (Private) Limited, is responsible for alluvial gold production along with the development of greenfield assets targeting bedrock gold and other potential metals & minerals. As MBMI is transitioning into commercial barite production, RRHI will now focus on building assets within TAG Minerals with the intent of moving into commercial production within the next 18 months. TAG Minerals will utilize the latest in Heavy Particle Concentrators (HPC-30/HPC-100) through its relationship with Extrac-TEC whose gold recovery and mineral separation technology captures up to 98% of alluvial gold down to 50 microns. The company is in early stage exploration evaluating potential alluvial sites to ensure they meet the company's criteria for commercial production. Coupled with MBMI's acquisition of WGB Kinsey & Company, TAG Minerals is well positioned to fast track into commercial production once the company has successfully completed its exploratory testing.

RRHI management continues to improve its balance sheet as reflected in the company's SEC 10k filing, including favorable reductions in the company's debt/liabilities and securing 54.4M shares and 14.4M warrants of RRHI from prior employees. The company is committed to growing its asset base in TAG Minerals moving forward. Disclaimer

Raptor Resources Holdings Inc. Company Blog

Raptor Resources Holdings Inc. News:

Mabwe Minerals Commences Mining Operations at Dodge Mine

Mabwe Minerals Frames Strategic Alliances With Steinbock Minerals Ltd. and Yasheya Ltd.

Mabwe Minerals Inc. Announces Engagement of QualityStocks Investor Relations Services

On the Move Systems Corp. (OMVS) Pursuing Intermodal Transport Partner to Advance Online Freight Portal

On the Move Systems Corp., a developer of online tools to designed to reduce costs and increase convenience in the tourism and transportation industry, today said it is seeking partnership with intermodal transport companies to which OMVS will offer the opportunity to provide the first services made available on its online transportation and freight portal, currently under development.

OMVS expects that it will soon sign its first partnering agreement with a freight carrier, representing the first step toward testing the new portal using the company’s proprietary transportation assets. The broader aim is to revolutionize the way cargo transport services are bought and sold by developing a new online platform that utilizes the same business model used by companies such as Expedia and Travelocity and applies the model to travel and transportation options not offered by larger competitors.

“This is a novel approach to selling these services designed to offer competitive rates to buyers and to help carriers fill each plane, ship and container to capacity,” OMVS CEO Robert Wilson stated in the press release. “We’re thrilled to have received a tremendous response from the private charter and freight companies we’ve already spoken with, and we expect to fill out our network of service providers very quickly.”

OMVS recently signed a development partnership agreement with ByterDyne, an architect of scalable, custom software solutions across the energy, transportation/logistics, and e-commerce industries. The two companies are collaborating to develop OMVS’ ISTx platform, the core of an online portal designed to connect users with discounted transportation options, including charter jet service, luxury ground shuttles, and more.

For more information, visit www.onthemovesystems.com

DoMark International, Inc. (DOMK) Adds to Imagic Ltd. Position Ahead of SmartLink Global Launch

Today before the opening bell, DoMark International, the smartphone, tablet, and video gaming accessories company, reported additional cash investment into Imagic Ltd. that subsequently increased ownership 31% and enabled a transaction in which Imagic has acquired all of the IP and rights to the Wireless Cartridge Printer.

Imagic now has two patent pending products. The SmartLink device connects virtually any smartphone or tablet wirelessly to the television set with 100% digital reproduction of movies and games, plus its handheld Smartlink games controller unit. The portable Imagic Cartridge Printer connects wirelessly to smartphone and tablets to produce inkless, high-resolution digital photographic prints.

With DoMark’s cash injection, it is anticipated that the funding of the tooling of the SmartLink products will be completed by end of October for launch late in Q4 of this year and early 2014. The launch of the Imagic wireless photograph printer is expected in Q2 of 2014 and by its unique use of its renewable cartridges is expected to bring in permanent cartridge replacement revenues. According to today’s release, branding and packaging consultants for all products are well in hand to coincide with manufacturers to achieve targets for the three SmartLink products launch dates.

Andy Ritchie, CEO of DoMark, commented: “I am delighted with the company’s progress this year, and I am confident that our family of unique patented or patent pending products are going to revolutionize their marketplace. I expect sales to start to generate strong revenues towards the end of this year and beginning of next year. This year has been one of building confidence commercially and with investors to demonstrate the value of our acquisitions and their products. We expect in the next few weeks to announce a distribution transaction for these products and for our IRCharger product, which has been delayed due to design changes required by our overseas customers.”

SmartLink Products – This product allows Smart Phones and Tablets to wirelessly connect Apps of movies or games to the television set with 100% instant reproduction without any fall off in quality or speed of response essential to movie fans and gaming enthusiasts. This essential quality markedly differentiates the SmartLink product against rival products such as the recently announced Google Chrome Dongle which failed in its expectation due to its lack of instant response and reproduction quality. The Smartlink games controller is expected to be ready for marketing at the same time as the SmartLink TV application and will come with ready to use games and movies to enhance its instant sales appeal.

SmartLink Potential Market – The worldwide video games industry is currently valued at 76 billion USD, with mobile being the fastest growing platform. The Smart Phone and tablet markets continues to grow in double digits monthly, with the accessory market for both growing at 50% yearly.

Imagic Printer – This ground breaking photographic printer uniquely does away with the purchase of consumables which are all contained in the easily loaded cartridge containing inkless paper, so obviating the need of ink or dyes or the loading of ribbons. This allows users to print out up to 24 postcard sized photographs, in high resolution, from their smartphone, tablets or digital cameras, immediately at any time and place, without the need to print from PC or use professional retail stores.

Other DoMark Products – These include the DoMark InfraSol IRCharger and Power+ light weight smartphone charger cases for Samsung Galaxy III, S4 and Apple iPhones. These products provide extended battery life in a slimline cover and are due to be available in Q4 this year and are expected to be in popular demand for which order enquiries have been received worldwide. The Zaktek PhonePad + product which allows a smartphone to be converted into a tablet, is due for launch by the UK’s largest mobile retail store chain this week, initially for use with Samsung mobile phones. (www.phonepadplus.com) Barefoot Science our patented FDA approved foot insole product sales continues to grow after the division has been restructured, receiving an order this week from one of Canada’s largest pharmacy retailers Shoppers Drugmart. DoMark’s 15% investment in Barefoot Science was acquired by the Company in 2012 and is now for sale due to the Company’s strategy in 2013 to concentrate on products in the fast growing mobile accessory market.

For more information, visit www.domark.com

Three Abstracts from Advaxis, Inc. (ADXS) Accepted for Presentation at Society for Immunotherapy of Cancer Annual Meeting

Advaxis, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, was pleased to announce today that three abstracts describing research with Advaxis Lm-LLO immunotherapies have been selected for poster presentation at the Society for Immunotherapy of Cancer (SITC) 28th Annual Meeting. This year’s meeting will take place November 8-10, 2013, at the Gaylord National Hotel & Convention Center in National Harbor, MD.

The abstract titled “Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment” has been selected for oral presentation during the session, “Tumor Microenvironment and Innate Cells Recognition” on November 8, 2013 from 9:40 AM to 12:00 PM. Anu Wallecha, Ph.D., Director of Research and Development at Advaxis, will report on the localized effects of Lm-LLO immunotherapies on the tumor microenvironment in preclinical studies using transplantable mouse models.

The abstract titled “ADXS11-001 immunotherapy targeting HPV-E7: Updated survival and safety data from a Phase 2 study in Indian women with recurrent/refractory cervical cancer” has been selected for poster presentation during the Vaccine session. Robert Petit, Ph.D., Chief Scientific Officer of Advaxis, will present final 18-month survival and updated safety data from the ongoing trial.

The abstract titled “Biomarker identification in serum samples from patients with recurrent cervical cancer treated with ADXS11-001 immunotherapy” has been selected for poster presentation during the session “Biomarkers and Immunoscoring”. Poonam Molli, Ph.D., Senior Scientist at Advaxis, will report on the correlation of changes in cytokine and chemokine levels pre- and post-dosing with ADXS11-001 from the Phase 2 study in Indian women with recurrent/refractory cervical cancer.

“The three presentations of Advaxis data at SITC reflect our growing understanding of the unique attributes of the Advaxis platform technology for immunotherapies. Dr. Wallecha’s presentation will highlight the ability of Lm-LLO immunotherapy to counteract immune suppressor cells that enable persistence of the tumor. We will report final 18-month survival and final tumor response data from our 110 patient Phase 2 study in India in women with recurrent cervical cancer. Dr. Molli’s presentation will illustrate the remarkable immune stimulation that occurs in patients after treatment with ADXS11-001. Together, these data paint a picture of an immunotherapy that has a strong positive impact on the immune system while at the same time counteracting immune suppression in the tumor microenvironment that can lead to apparent prolonged survival and objective tumor responses from a single immunotherapeutic agent,” commented Dr. Petit.

For additional information, please visit: www.ADXS.MissionIR.com

Epazz Inc. (EPAZ) On Pace to Grow Market Value in Competitive Industry

Epazz is an enterprise-wide software company that specializes in providing customized Web applications that are applicable across the full breadth of companies in the corporate, higher education, non-profit, and public sectors.

The company’s BoxesOS applications create virtual communities, provide information and content for decision-making, and create a secure marketplace for any type of commerce all through the medium of the Internet. These solutions result in enhanced communication, reduced costs, and create sources of additional revenue.

In regards to its own growth, EPAZ has grown more than 300 percent in the last three years, demonstrating substantial growth in a highly competitive industry. Its strategy is based on four primary fundamentals.

• Organic growth of in-house products and services
• Growth through acquisition of synergistic and strong revenue companies
• Diversifying streams of income
• Building shareholder value through acquisitions and spinoffs with dividend to shareholders

The company believes that accelerating its growth on the business side will serve as a catalyst for more marketplace value. This growth starts by building a solid client base, which EPAZ has successfully grown by more than 500 percent in the last three years. Company management believes this is just the start of continued expansion built on high renewal rates and new customer additions.

EPAZ is currently considering several acquisition targets that it sees as high-potential, profitable B2B businesses that may boost the company’s bottom line and keep it among the top contenders in the competitive application software industry.

For more information visit www.Epazz.com


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters







Stock Twiter

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251